KKR Affiliate Injects $150M, Launches $150M Tender Offer, and FSK Authorizes $300M Buyback to Boost Value
Summary
FS KKR Capital Corp. announced a multi-pronged strategy including a $150 million convertible preferred stock investment from a KKR affiliate, a $150 million tender offer for common stock at a premium, and a $300 million share repurchase program, alongside a fee waiver, to address recent financial declines and boost shareholder value.
Key Events
-
KKR Affiliate Invests $150M in Convertible Preferred Stock
KKR Alternative Assets L.P. agreed to purchase $150 million in newly issued convertible perpetual preferred stock at a liquidation preference of $25.00 per share, with an initial conversion price of $18.83 (matching NAV). This provides a significant capital injection for general corporate purposes, including potential share repurchases or debt repayment.
-
KKR Subsidiary to Launch $150M Tender Offer
A KKR subsidiary intends to launch a fixed-price tender offer for up to $150 million of FSK common stock at $11.00 per share, representing a premium to the current market price, aiming to support the common stock value.
-
Board Authorizes $300M Share Repurchase Program
The board authorized a $300 million stock repurchase program, to be implemented after the tender offer, further demonstrating commitment to shareholder value and stock price support.
-
KKR Waives 50% of Subordinated Income Incentive Fee
KKR agreed to waive 50% of the total subordinated income incentive fee for four consecutive quarters, starting Q2 2026, which is expected to support net investment income and quarterly distributions.
Analysis
This filing details a comprehensive strategic plan by FS KKR Capital Corp. and its affiliate, KKR Alternative Assets L.P., to stabilize the company and enhance shareholder value following a challenging first quarter. The significant capital injection through convertible preferred stock, coupled with a tender offer and a substantial share repurchase program, demonstrates a strong commitment from KKR to support the company's stock price and financial position. The fee waiver further improves net investment income, aiming to stabilize distributions. These actions are a direct response to recent poor financial performance and credit downgrades, signaling a major effort to reverse negative trends.
At the time of this filing, FSK was trading at $10.52 on NYSE in the Unknown sector, with a market capitalization of approximately $3B. The 52-week trading range was $9.72 to $22.68. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.